Search Results
Found 6,153 results for "cps products"
Safety Alert
Health Canada
Health CanadaArchived – Conditional Approval of Viread (Tenofovir Disoproxil Fumarate) – Gilead Sciences, Inc.
Marketed health products
Health CanadaGeneral Alert
Archived – Conditional Approval of Viread (Tenofovir Disoproxil Fumarate) – Gilead Sciences, Inc.
Product safety
May 10, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Association of Absorbable Hemostatic Agents with Paralysis or Other Neural Deficits – Notice to Hospitals
Marketed health products
Health CanadaGeneral Alert
Archived – Association of Absorbable Hemostatic Agents with Paralysis or Other Neural Deficits – Notice to Hospitals
Product safety
May 7, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Important Safety Update: Diarrhea and Ischemic Colitis in Patients Using ZELNORM (Tegaserod Hydrogen Maleate)
Marketed health products
Health CanadaGeneral Alert
Archived – Important Safety Update: Diarrhea and Ischemic Colitis in Patients Using ZELNORM (Tegaserod Hydrogen Maleate)
Product safety
May 6, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaInadequate Cleaning or Sterilization of EZ Clean Monobloc ACETABULAR REAMER – Notice to Hospitals
Marketed health products
Health CanadaGeneral Alert
Inadequate Cleaning or Sterilization of EZ Clean Monobloc ACETABULAR REAMER – Notice to Hospitals
Product safety
Apr 23, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Important Safety Information Concerning Liver Problems for Patients Taking ACCOLATE® (Zafirlukast) – AstraZeneca Canada Inc. – For the Public
Marketed health products
Health CanadaGeneral Alert
Archived – Important Safety Information Concerning Liver Problems for Patients Taking ACCOLATE® (Zafirlukast) – AstraZeneca Canada Inc. – For the Public
Product safety
Apr 19, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaImportant Safety Information Regarding Reports of Serious Hepatic Events in Patients Receiving ACCOLATE® (Zafirlukast) – For Health Professionals
Marketed health products
Health CanadaGeneral Alert
Important Safety Information Regarding Reports of Serious Hepatic Events in Patients Receiving ACCOLATE® (Zafirlukast) – For Health Professionals
Product safety
Apr 19, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Health Risks Associated with Use of INFUSION PUMPS – Notice to Hospitals
Marketed health products
Health CanadaGeneral Alert
Archived – Health Risks Associated with Use of INFUSION PUMPS – Notice to Hospitals
Product safety
Apr 16, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Updated Safety Information for ZYPREXA (Olanzapine) in Elderly Dementia Patients, Announced in Canada – Eli Lilly Canada Inc. – For the Public
Marketed health products
Health CanadaGeneral Alert
Archived – Updated Safety Information for ZYPREXA (Olanzapine) in Elderly Dementia Patients, Announced in Canada – Eli Lilly Canada Inc. – For the Public
Product safety
Mar 18, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Important Drug Safety Information: ZYPREXA (olanzapine) and Cerebrovascular Adverse Events in Placebo-Controlled Elderly Dementia Trials
Marketed health products
Health CanadaGeneral Alert
Archived – Important Drug Safety Information: ZYPREXA (olanzapine) and Cerebrovascular Adverse Events in Placebo-Controlled Elderly Dementia Trials
Product safety
Mar 17, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Important New Safety Information Clarifying Risk Factors for Severe, Life-threatening and Fatal Hepatotoxicity with VIRAMUNE® (Nevirapine)
Marketed health products
Health CanadaGeneral Alert
Archived – Important New Safety Information Clarifying Risk Factors for Severe, Life-threatening and Fatal Hepatotoxicity with VIRAMUNE® (Nevirapine)
Product safety
Mar 12, 2004Marketed health products
Safety Alert
CPSC
CPSCCPSC, Tristar Products Inc. Announce Recall of Revised Design Steam Cleaner
Tristar Products Inc., of Fairfield, N.J.
CPSCGeneral Alert
CPSC, Tristar Products Inc. Announce Recall of Revised Design Steam Cleaner
Hot water and steam can escape from the steam cleaner's handle and inner hose, posing a burn hazard to consumers.
Mar 9, 2004Tristar Products Inc., of Fairfield, N.J.
Safety AlertHealth Canada
Health CanadaArchived – Association of Tazocin® (Piperacillin/Tazobactam) with False Positive Results of the Bio-Rad Aspergillus Assay
Marketed health products
Health CanadaGeneral Alert
Archived – Association of Tazocin® (Piperacillin/Tazobactam) with False Positive Results of the Bio-Rad Aspergillus Assay
Product safety
Mar 9, 2004Marketed health products
Safety AlertCPSC
CPSCCPSC, Lasko Products Inc. Announce Recall of Space Heaters
Unknown Firm
CPSCGeneral Alert
CPSC, Lasko Products Inc. Announce Recall of Space Heaters
The power cord connection can overheat and cause the cord to separate from the space heater. This poses a fire, burn and shock hazard.
Mar 4, 2004
Safety AlertHealth Canada
Health CanadaArchived – Important Safety Information Regarding the Antiparkinson Drug PERMAX® (Pergolide Mesylate): Sudden Onset of Sleep
Marketed health products
Health CanadaGeneral Alert
Archived – Important Safety Information Regarding the Antiparkinson Drug PERMAX® (Pergolide Mesylate): Sudden Onset of Sleep
Product safety
Feb 17, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Important Safety Information Regarding TAMIFLU® (Oseltamivir Phosphate) and Prescription in Children Less Than One Year of Age
Marketed health products
Health CanadaGeneral Alert
Archived – Important Safety Information Regarding TAMIFLU® (Oseltamivir Phosphate) and Prescription in Children Less Than One Year of Age
Product safety
Feb 9, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Information for Patients Regarding a Drug Interaction Between RITONAVIR (Norvir/Kaletra) and FLUTICASONE Propionate (Flonase, Flovent, Advair) – GlaxoSmithKline Inc. – For the Public
Marketed health products
Health CanadaGeneral Alert
Archived – Information for Patients Regarding a Drug Interaction Between RITONAVIR (Norvir/Kaletra) and FLUTICASONE Propionate (Flonase, Flovent, Advair) – GlaxoSmithKline Inc. – For the Public
Product safety
Feb 2, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Important Safety Information Regarding a Drug Interaction Between Fluticasone Propionate (Flonase /Flovent /Advair ) and Ritonavir (Norvir /Kaletra )
Marketed health products
Health CanadaGeneral Alert
Archived – Important Safety Information Regarding a Drug Interaction Between Fluticasone Propionate (Flonase /Flovent /Advair ) and Ritonavir (Norvir /Kaletra )
Product safety
Jan 30, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Updated Safety Information Announced in Canada for Patients Taking TOPAMAX (Topiramate) Regarding Higher than Normal Blood Acid Levels – Janssen-Ortho Inc. – For the Public
Marketed health products
Health CanadaGeneral Alert
Archived – Updated Safety Information Announced in Canada for Patients Taking TOPAMAX (Topiramate) Regarding Higher than Normal Blood Acid Levels – Janssen-Ortho Inc. – For the Public
New safety information
Jan 26, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – TOPAMAX (topiramate) Use is Associated with Metabolic Acidosis
Marketed health products
Health CanadaGeneral Alert
Archived – TOPAMAX (topiramate) Use is Associated with Metabolic Acidosis
Product safety
Jan 21, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Important Drug Safety Information: EPREX (Epoetin Alfa) Sterile Solution: Revised Prescribing Information for Patients with Chronic Renal Failure
Marketed health products
Health CanadaGeneral Alert
Archived – Important Drug Safety Information: EPREX (Epoetin Alfa) Sterile Solution: Revised Prescribing Information for Patients with Chronic Renal Failure
New safety information
Jan 15, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Updated Safety Information about EPREX (Epoetin Alfa) Provided to Canadian Healthcare Professionals – For The Public
Marketed health products
Health CanadaGeneral Alert
Archived – Updated Safety Information about EPREX (Epoetin Alfa) Provided to Canadian Healthcare Professionals – For The Public
New safety information
Jan 15, 2004Marketed health products
Safety AlertCPSC
CPSCCPSC, Graco Children's Products Announce Recall of Bumble Bee Toys with Blue Antennae
Graco Children's Products, Inc. of Exton, Pa.
CPSCGeneral Alert
CPSC, Graco Children's Products Announce Recall of Bumble Bee Toys with Blue Antennae
The blue antennae on the Bumble Bee toy can break, posing a choking hazard to young children.
Jan 14, 2004Graco Children's Products, Inc. of Exton, Pa.
Safety AlertHealth Canada
Health CanadaArchived – Important Safety Information Regarding the Use of SEVORANE AF (Sevoflurane) in Conjunction with Anesthesia Machines
Marketed health products
Health CanadaGeneral Alert
Archived – Important Safety Information Regarding the Use of SEVORANE AF (Sevoflurane) in Conjunction with Anesthesia Machines
Product safety
Jan 8, 2004Marketed health products
Safety AlertHealth Canada
Health CanadaArchived – Serious Liver Injury with TEBRAZID (Pyrazinamide) or PMS-pyrazinamide and Rifampin for the Treatment of Latent Tuberculosis – ICN Canada Limited and Pharmascience Inc. – For the Public
Marketed health products
Health CanadaGeneral Alert
Archived – Serious Liver Injury with TEBRAZID (Pyrazinamide) or PMS-pyrazinamide and Rifampin for the Treatment of Latent Tuberculosis – ICN Canada Limited and Pharmascience Inc. – For the Public
Product safety
Jan 6, 2004Marketed health products